| Stage | IBP | % of rev | LEN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $778M | 100.00% | $8.0B | 100.00% | LEN ×10.34 |
| Gross profit | $259M | 33.29% | $619M | 7.69% | IBP +25.6pp |
| Operating income | $95M | 12.16% | $460M | 5.71% | IBP +6.4pp |
| Pre-tax income | $85M | 10.94% | $387M | 4.81% | IBP +6.1pp |
| Net income | $65M | 8.34% | $285M | 3.55% | IBP +4.8pp |
| Stage | IBP | LEN | Gap · A − B |
|---|---|---|---|
| Revenue | $778M100.00% | $8.0B100.00% | LEN ×10.34 |
| Gross profit | 33.29%$259M | 7.69%$619M | IBP +25.6pp |
| Operating income | 12.16%$95M | 5.71%$460M | IBP +6.4pp |
| Pre-tax income | 10.94%$85M | 4.81%$387M | IBP +6.1pp |
| Net income |
| 8.34%$65M |
| 3.55%$285M |
| IBP +4.8pp |
No shared counterparties.